Loading organizations...
§ Private Profile · Irvine, CA, USA
Medical device company developing and manufacturing portable, non-invasive ventilators for lung diseases and respiratory insufficiency.
Founded in 2005 and based in Irvine, California, Breathe Technologies develops and manufactures innovative medical devices for treating lung diseases and sleep-disordered breathing. The company focuses on the respiratory care market, providing the wearable Life2000 Ventilation System to support patients with conditions like COPD, interstitial lung disease, and restrictive thoracic disorders in both homecare and critical-care institutional settings while enabling patient mobility. Under the leadership of executives including CEO Lawrence A. Mastrovich and Chairman John Miclot, the firm successfully secured FDA clearance for the first and second generations of its non-invasive ventilation devices. Prior to its acquisition, the enterprise raised $68.24 million in total funding and generated approximately $10 million in annual revenue through its direct medical device product sales. The business was ultimately acquired by Hillrom for $130 million to further expand its respiratory care portfolio.
Breathe Technologies has raised $45.8M across 4 funding rounds.
Breathe Technologies has raised $45.8M in total across 4 funding rounds.
Breathe Technologies has raised $45.8M across 4 funding rounds. Most recently, it raised $810K Series U in January 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 1, 2015 | $810K Series U | — | Westlake Village BioPartners | Announced |
| Jun 1, 2014 | $7M Series D | — | Westlake Village BioPartners | Announced |
| May 1, 2010 | $23M Series C | DAG Ventures | Westlake Village BioPartners, Delphi Ventures, Johnson & Johnson Innovation, Kleiner Perkins, Synergy Ventures | Announced |
| Mar 1, 2008 | $15M Series B | — | Westlake Village BioPartners | Announced |
Breathe Technologies is a medical technology company that developed a portable, wearable, non-invasive ventilator device to treat lung diseases and respiratory insufficiency, enabling patients with chronic respiratory conditions to maintain an active lifestyle in home or institutional settings.[1][2][3] The company served healthcare providers and patients needing optimized breathing and mobility support, addressing the problem of limited mobility for those reliant on traditional bulky ventilators.[1][3] Founded in 2005 in Irvine, California, it raised $68.24M before being acquired, reflecting strong early growth in the respiratory tech space.[1]
Breathe Technologies was founded in 2005 in Irvine, California, at 15091 Bake Parkway, with a focus on innovative medical devices for respiratory care.[1] The core idea emerged from the need to create compact, wearable solutions for patients with neuromuscular diseases and respiratory insufficiency, moving beyond stationary ventilators to support daily mobility.[2][3] Early traction built through development of its flagship non-invasive ventilator, culminating in significant funding ($68.24M total) and acquisition by Hillrom, marking a pivotal validation of its technology.[1][4]
Breathe Technologies rode the trend toward portable, patient-centric medtech amid rising demand for home-based respiratory care, driven by aging populations and chronic conditions like COPD.[1][2] Timing aligned with advances in miniaturization and non-invasive ventilation, amplified by market forces such as post-pandemic emphasis on respiratory health and homecare shifts.[1][3] By pioneering wearable ventilators, it influenced the ecosystem, paving the way for acquisitions like Hillrom's, which integrated its tech into larger healthcare solutions and boosted innovation in mobility-focused respiratory devices.[4]
Post-acquisition by Hillrom, Breathe Technologies' tech likely integrates into broader respiratory portfolios, with next steps focusing on scaling distribution and potential enhancements via AI-driven personalization or expanded indications.[1][4] Trends like remote monitoring and value-based care will shape its trajectory, evolving its influence toward seamless homecare ecosystems. This positions it as a foundational player in empowering respiratory patients, tying back to its origins in liberating users from stationary devices for truly active lives.[1][2]
Breathe Technologies has raised $45.8M in total across 4 funding rounds.
Breathe Technologies's investors include Westlake Village BioPartners, DAG Ventures, Delphi Ventures, Johnson & Johnson Innovation, Kleiner Perkins, Synergy Ventures.